On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Everest Medicines’ Nefecon achieved 167 million yuan in sales in just over a month after its launch, showing its future big ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Researchers are exploring a new mRNA delivery technique to treat genetic conditions in the fetal brain, potentially ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...

Volunteers are currently being sought in Japan, Canada, Australia and the UK for a clinical trial to develop the world's ...